170 related articles for article (PubMed ID: 30029629)
41. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.
Zhang S; Luo J; Li J; Wu Z; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
Clin Chem Lab Med; 2017 May; 55(6):865-875. PubMed ID: 27831916
[TBL] [Abstract][Full Text] [Related]
42. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.
Coskun M; Bjerrum JT; Seidelin JB; Troelsen JT; Olsen J; Nielsen OH
World J Gastroenterol; 2013 Jul; 19(27):4289-99. PubMed ID: 23885139
[TBL] [Abstract][Full Text] [Related]
43. Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis.
Odes HS; Fich A; Reif S; Halak A; Lavy A; Keter D; Eliakim R; Paz J; Broide E; Niv Y; Ron Y; Villa Y; Arber N; Gilat T
Dig Dis Sci; 2001 Aug; 46(8):1717-21. PubMed ID: 11508673
[TBL] [Abstract][Full Text] [Related]
44. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease].
Lecis P; Germanà B; Papa N; Bertiato G; Doglioni C; Galliani E; Biedo FC
Recenti Prog Med; 2002 May; 93(5):308-13. PubMed ID: 12050913
[TBL] [Abstract][Full Text] [Related]
45. Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy.
Colombel JF; Jharap B; Sandborn WJ; Feagan B; Peyrin-Biroulet L; Eichner SF; Robinson AM; Mostafa NM; Zhou Q; Thakkar RB
Aliment Pharmacol Ther; 2017 Jan; 45(1):50-62. PubMed ID: 27883215
[TBL] [Abstract][Full Text] [Related]
46. Need for infliximab dose intensification in Crohn's disease and ulcerative colitis.
Taxonera C; Olivares D; Mendoza JL; Díaz-Rubio M; Rey E
World J Gastroenterol; 2014 Jul; 20(27):9170-7. PubMed ID: 25083091
[TBL] [Abstract][Full Text] [Related]
47. Similar risk of depression and anxiety following surgery or hospitalization for Crohn's disease and ulcerative colitis.
Ananthakrishnan AN; Gainer VS; Cai T; Perez RG; Cheng SC; Savova G; Chen P; Szolovits P; Xia Z; De Jager PL; Shaw S; Churchill S; Karlson EW; Kohane I; Perlis RH; Plenge RM; Murphy SN; Liao KP
Am J Gastroenterol; 2013 Apr; 108(4):594-601. PubMed ID: 23337479
[TBL] [Abstract][Full Text] [Related]
48. Systematic Review and Meta-Analysis: Risk of Hospitalization in Patients with Ulcerative Colitis and Crohn's Disease in Population-Based Cohort Studies.
Tsai L; Nguyen NH; Ma C; Prokop LJ; Sandborn WJ; Singh S
Dig Dis Sci; 2022 Jun; 67(6):2451-2461. PubMed ID: 34379220
[TBL] [Abstract][Full Text] [Related]
49. Colorectal adenocarcinoma in Crohn's disease: a retrospective histologic study.
Rubio CA; Befrits R
Dis Colon Rectum; 1997 Sep; 40(9):1072-8. PubMed ID: 9293938
[TBL] [Abstract][Full Text] [Related]
50. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
[TBL] [Abstract][Full Text] [Related]
51. Improving case definition of Crohn's disease and ulcerative colitis in electronic medical records using natural language processing: a novel informatics approach.
Ananthakrishnan AN; Cai T; Savova G; Cheng SC; Chen P; Perez RG; Gainer VS; Murphy SN; Szolovits P; Xia Z; Shaw S; Churchill S; Karlson EW; Kohane I; Plenge RM; Liao KP
Inflamm Bowel Dis; 2013 Jun; 19(7):1411-20. PubMed ID: 23567779
[TBL] [Abstract][Full Text] [Related]
52. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis.
Ananthakrishnan AN; Long MD; Martin CF; Sandler RS; Kappelman MD
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):965-71. PubMed ID: 23376797
[TBL] [Abstract][Full Text] [Related]
53. Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis.
Mao EJ; Hazlewood GS; Kaplan GG; Peyrin-Biroulet L; Ananthakrishnan AN
Aliment Pharmacol Ther; 2017 Jan; 45(1):3-13. PubMed ID: 27862107
[TBL] [Abstract][Full Text] [Related]
54. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
[TBL] [Abstract][Full Text] [Related]
55. Endoscopic ultrasound of the colon for the differentiation of Crohn's disease and ulcerative colitis in comparison with healthy controls.
Ellrichmann M; Wietzke-Braun P; Dhar S; Nikolaus S; Arlt A; Bethge J; Kuehbacher T; Wintermeyer L; Balschun K; Klapper W; Schreiber S; Fritscher-Ravens A
Aliment Pharmacol Ther; 2014 Apr; 39(8):823-33. PubMed ID: 24612000
[TBL] [Abstract][Full Text] [Related]
56. Burden of Fatigue Among Patients with Ulcerative Colitis and Crohn's Disease: Results from a Global Survey of Patients and Gastroenterologists.
Regueiro M; Hunter T; Lukanova R; Shan M; Wild R; Knight H; Bannikoppa P; Naegeli AN
Adv Ther; 2023 Feb; 40(2):474-488. PubMed ID: 36370288
[TBL] [Abstract][Full Text] [Related]
57. Tissue IgG4-positive plasma cells in inflammatory bowel disease: a study of 88 treatment-naive biopsies of inflammatory bowel disease.
Virk R; Shinagare S; Lauwers GY; Yajnik V; Stone JH; Deshpande V
Mod Pathol; 2014 Mar; 27(3):454-9. PubMed ID: 23929268
[TBL] [Abstract][Full Text] [Related]
58. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers.
Quaglio AEV; Santaella FJ; Rodrigues MAM; Sassaki LY; Di Stasi LC
World J Gastroenterol; 2021 Dec; 27(45):7801-7812. PubMed ID: 34963743
[TBL] [Abstract][Full Text] [Related]
59. [Differences by age in clinical features of inflammatory bowel disease].
Simian D; Estay C; Kronberg U; Yarur A; Castro M; Lubascher J; Acuña R; Quera R
Rev Med Chil; 2015 Jun; 143(6):689-96. PubMed ID: 26230551
[TBL] [Abstract][Full Text] [Related]
60. Time between suspected and confirmed diagnoses of Crohn's disease and ulcerative colitis in patients followed in gastroenterological practices in Germany.
Kostev K; Konrad M; Jacob L
Int J Colorectal Dis; 2018 Jul; 33(7):967-971. PubMed ID: 29721733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
